REGENXBIO Inc. (RGNX)

REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	56.62	34.52	96.95	345.21	338.43	69.51
Short-Term Investments	198.84	240.74	267.69	112.23	137.31	226.7
Cash & Short-Term Investments	255.46	275.26	364.64	457.44	475.74	296.21
Cash Growth	-15.38%	-24.51%	-20.29%	-3.85%	60.61%	-7.37%
Accounts Receivable	23.6	24.79	28.08	28.51	43.35	38.15
Other Receivables	21.88	19.3	8.5	-	-	-
Receivables	45.48	44.09	36.59	28.51	43.35	38.15
Prepaid Expenses	11	14.52	13.9	18.75	10.51	6.48
Other Current Assets	1.45	1.11	0.85	14.12	1.6	4.2
Total Current Assets	313.4	334.97	415.98	518.83	531.2	345.03
Property, Plant & Equipment	175.84	192.59	206.8	192.45	120.28	39.05
Long-Term Investments	23.11	38.87	200.56	391.91	47.91	103.79
Long-Term Accounts Receivable	0.4	0.7	1.5	2.26	3.27	4.16
Other Long-Term Assets	6.36	6.84	8.43	8.46	5.51	5.89
Total Assets	519.11	573.97	833.27	1,114	708.16	497.91
Accounts Payable	19.52	22.79	27.21	11.39	10.62	6.41
Accrued Expenses	48.31	49.32	45.99	59.5	38.09	23.52
Current Portion of Long-Term Debt	26.7	50.57	48.6	37.89	18.79	-
Current Portion of Leases	7.72	7.07	6	1.75	2.5	2.42
Current Income Taxes Payable	-	-	-	11.33	3.14	-
Current Unearned Revenue	0.14	0.15	1.83	3.33	0.45	-
Other Current Liabilities	0.33	0.39	0.81	5.29	7.85	1.33
Total Current Liabilities	102.73	130.27	130.43	130.47	81.45	33.68
Long-Term Debt	35.05	43.49	89.01	133.46	174.5	-
Long-Term Leases	76.34	82.22	88.8	84.93	70.15	8.87
Long-Term Unearned Revenue	-	-	-	-	3.78	3.33
Other Long-Term Liabilities	3.58	6.25	8.83	0.75	0.52	1.83
Total Liabilities	217.7	262.23	317.07	349.61	330.41	47.71
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	1,183	1,021	973.15	928.1	667.18	627.81
Retained Earnings	-880.96	-705.05	-441.55	-161.23	-289.07	-177.82
Comprehensive Income & Other	-0.58	-4.43	-15.4	-2.57	-0.36	0.21
Total Common Equity	301.42	311.74	516.2	764.3	377.75	450.2
Shareholders' Equity	301.42	311.74	516.2	764.3	377.75	450.2
Total Liabilities & Equity	519.11	573.97	833.27	1,114	708.16	497.91
Total Debt	145.81	183.34	232.41	258.03	265.95	11.3
Net Cash (Debt)	132.76	130.79	332.8	591.32	256.6	388.7
Net Cash Growth	-20.97%	-60.70%	-43.72%	130.44%	-33.99%	-16.36%
Net Cash Per Share	2.78	2.99	7.71	13.47	6.88	10.59
Filing Date Shares Outstanding	49.55	44.43	43.46	42.95	42.5	37.14
Total Common Shares Outstanding	49.53	44.05	43.3	42.83	37.48	36.99
Working Capital	210.67	204.7	285.54	388.35	449.75	311.36
Book Value Per Share	6.09	7.08	11.92	17.84	10.08	12.17
Tangible Book Value	301.42	311.74	516.2	764.3	377.75	450.2
Tangible Book Value Per Share	6.09	7.08	11.92	17.84	10.08	12.17
Machinery	88.56	87.38	83.68	68.05	34.18	24.4
Leasehold Improvements	101.34	101.93	99.4	92.54	44.96	18.92

Source: S&P Capital IQ. Standard template. Financial Sources.